How does acalabrutinib work

Cancer cells get signals to grow and divide from a protein called Bruton tyrosine kinase (BTK). Acalabrutinib mechanism of action is by blocking BTK this helps to stop cancer cells from growing and multiplying, to help reduce cancer growth. Acalabrutinib class of medications is called BTK inhibitors and is a targeted therapy. Acalabrutinib is not chemotherapy.